Perrigo Stock Analysis (NYSE:PRGO)

Add to My Stocks
$84.09 $0.58 (0.69%) PRGO stock closing price Feb 22, 2017 (Closing)
Watch Robo Advisor Video of PRGO Stock Analysis
Perrigo
Updated on : Feb 22, 2017
previous close
PRGO 84.1 (0%)
S&P 500 2362.8 (0%)
Closing Price On: Feb 22, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$billion
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
14.7%
Operating Profit
Operating Margin:
-46.5%
Sector Average:
-1.1%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Debt/Equity Ratio
Debt:
5.64B
Debt/Equity Ratio:
 0.65
Compared to the industry
Cash Flow
Operating cash flow:
$303.9M
Net Income:
-$1.26B
Dividend Yield
PRGO dividend yield:
0.69%
PROS      CONS
FCF Margin
PE Valuation
PS Valuation
Long Term Growth
Operating Margins
Net Margins
High Debt Burden
ROIC
ROE
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
PRGO PS :
2.1
Industry PS :
4.6
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
-12.7%
Return on Equity:
-15.3%
Free Cash Flow Margin:
20.4%
Double Tap To Exit Full Screen
0:00
/

Perrigo Analysis Video

256 5 2

View Perrigo stock analysis video. This is our PRGO analyst opinion covering the buy and sell arguments for PRGO stock.

Perrigo Company plc Ordinary Shares Stock Rating (2.6/5)

Our Perrigo stock opinion is based on fundamentals of the company. This Perrigo stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy PRGO stock?

  • The price to earnings multiple of 11.8 is attractive when compared with the industry average PE ratio of 22.5.
  • When compared with the Medical Products industry average PS ratio of 4.6, the price-to-sales ratio of 2.1 for PRGO stock is attractive.
  • The company has a good Free Cash Flow (FCF) margin of 20.4%.

Should you sell PRGO stock?

  • Over the last 5 years, the company registered a poor revenue growth of .
  • Over the last twelve months, Perrigo posted an average operating loss margin of -46.5%.
  • Over the last 12 months, Perrigo had an average Net loss of -26.6%.
  • Perrigo has a debt/equity ratio of  0.65, which is worse than the average in the Medical sector.
  • Perrigo has a negative ROIC (Return on Invested Capital) of -12.7%.
  • A negative ROE of -15.3% indicates that the company is not able to generate profits with the money shareholders have invested.

Comments on this video and Perrigo stock

Related to Perrigo Company plc Ordinary Shares Analysis